Cover [Abstract] Document Type Document Type Document Quarterly Report Document Quarterly Report Document Period End Date Document Period End Date Document Transition Report Document Transition Report Entity File Number Entity File Number Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address Address Line1 Entity Address, Address Line One Entity Address Address Line2 Entity Address, Address Line Two Entity Address Address Line3 Entity Address, Address Line Three Entity Address City Or Town Entity Address, City or Town Entity Address State Or Province Entity Address, State or Province Entity Address Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Security12b Title Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Statement Of Financial Position [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Assets [Abstract] ASSETS Assets Current [Abstract] CURRENT ASSETS: Cash And Cash Equivalents At Carrying Value Cash and cash equivalents Short-Term Investments Investments, short-term Accounts Receivable Net Current Trade receivables, net Inventory Net Inventory, net Total inventory, net Prepaid Expense Current Prepaid expenses Other Assets Current Other current assets Assets Current Total current assets Assets Noncurrent [Abstract] NONCURRENT ASSETS: Property Plant And Equipment Net Property and equipment, net Restricted Cash Noncurrent Restricted cash Long-Term Investments Investments, long-term Intangible Assets Net Excluding Goodwill Intangible assets, net Net Book Value Deferred Income Tax Assets, Net Deferred tax asset Other Assets Noncurrent Other noncurrent assets Assets Noncurrent Total noncurrent assets Assets TOTAL ASSETS Liabilities And Stockholders Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities Current [Abstract] CURRENT LIABILITIES: Accounts Payable Current Trade payables Accrued Employee Benefits Current Accrued compensation Accrued Liabilities Current Accrued expenses Accrued expenses Long-term Debt, Current Maturities Less current portion Current portion of long-term debt Other Liabilities Current Other current liabilities Liabilities Current Total current liabilities Liabilities Noncurrent [Abstract] NONCURRENT LIABILITIES: Long Term Debt Noncurrent Long-term debt, net Other Liabilities Noncurrent Other noncurrent liabilities Liabilities Noncurrent Total noncurrent liabilities Liabilities TOTAL LIABILITIES Commitments And Contingencies COMMITMENTS AND CONTINGENCIES (Note 12) Stockholders Equity [Abstract] STOCKHOLDERS' EQUITY: Common Stock Value Common stock-$0.00001 par value; 500,000,000 shares authorized at September 30, 2022 and December 31, 2021, respectively; 59,304,408 shares and 58,825,769 issued and outstanding at September 30, 2022 and December 31, 2021, respectively Additional Paid In Capital Common Stock Additional paid in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income (loss) Retained Earnings Accumulated Deficit Accumulated deficit Accumulated deficit Stockholders Equity Ending balance Beginning balance TOTAL STOCKHOLDERS' EQUITY Liabilities And Stockholders Equity TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Common Stock Par Or Stated Value Per Share Common stock, par value Common Stock Shares Authorized Common stock, shares authorized Common Stock Shares Issued Common stock, shares issued Common Stock Shares Outstanding Common stock, shares outstanding Income Statement [Abstract] Revenue From Contract With Customer Excluding Assessed Tax Net product revenues Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Cost Of Goods And Services Sold Cost of product sold Cost, Product and Service [Extensible Enumeration] Gross Profit Gross profit Operating Expenses [Abstract] Operating expenses: Research And Development Expense. Research and development Selling And Marketing Expense Sales and marketing General And Administrative Expense. General and administrative Operating Expenses Total operating expenses Operating Income Loss Operating income Gains Losses On Extinguishment Of Debt Loss on debt extinguishment Loss on debt extinguishment Other Nonoperating Income Expense Other expense (income), net Interest Income Expense Nonoperating Net Interest expense, net Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income (loss) before income taxes Income Tax Expense Benefit Income tax benefit (expense) Net Income Loss Net income Net income Net income Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Unrealized loss on investments Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income Earnings Per Share [Abstract] EARNINGS PER SHARE: Denominator Earnings Per Share Basic Basic Net income per common share - basic Earnings Per Share Diluted Diluted Net income per common share - diluted Weighted Average Number Of Shares Outstanding Basic Weighted average number of shares of common stock - basic Weighted Average Number Of Diluted Shares Outstanding Weighted average number of shares of common stock - diluted Statement Of Stockholders Equity [Abstract] Statement Equity Components [Axis] Equity Component Common Stock Additional Paid-in Capital Accumulated other comprehensive income (loss ) Accumulated Deficit Shares Outstanding Ending balance, shares Beginning balance, shares Stock Issued During Period, Value, New Issues Issuance of common stock Stock Issued During Period Shares New Issues Issuance of common stock (in shares) Issuance of common stock, Shares Stock Issued During Period Value Stock Options Exercised Exercise of stock options Stock Issued During Period Shares Stock Options Exercised Number of Awards, Awards exercised Exercise of stock options, Shares Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Stock-based compensation Statement Of Cash Flows [Abstract] Net Cash Provided By Used In Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Profit Loss Net income Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net income to net cash used in operating activities: Depreciation Depreciation Amortization Of Intangible Assets Intangible amortization Amortization expense Share Based Compensation Stock-based and employee stock purchase compensation expense Stock appreciation rights market adjustment. Stock Appreciation Rights Market Adjustment Stock appreciation rights market adjustment Amortization Of Financing Costs Debt issuance costs amortization Amortization of deferred financing costs Deferred Income Tax Expense Benefit Deferred taxes Investment Income, Interest Investment securities interest income Other Noncash Expense Other non-cash expenses Increase Decrease In Operating Capital [Abstract] Change in operating assets and liabilities: Increase Decrease In Accounts Receivable Trade receivables Increase Decrease In Inventories Inventory Increase Decrease In Prepaid Deferred Expense And Other Assets Prepaid expenses and other assets Increase Decrease In Accounts Payable Trade Trade payables Increase Decrease In Accrued Liabilities And Other Operating Liabilities Accrued expenses and other current liabilities Increase Decrease In Other Noncurrent Liabilities Other non-current liabilities Net Cash Provided By Used In Operating Activities Net cash provided by operating activities Net Cash Provided By Used In Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: Payments to Acquire Debt Securities, Available-for-Sale Purchase of investment securities Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Proceeds from maturities and sales of investment securities Payments To Acquire Property Plant And Equipment Purchase of property and equipment Cash paid during the year for milestones. Cash Paid For Milestones Milestone payments Net Cash Provided By Used In Investing Activities Net cash used in investing activities Net Cash Provided By Used In Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds From Issuance Of Common Stock Proceeds from issuance of common stock Payments Of Stock Issuance Costs Common stock issuance costs Underwriting discounts and commissions and offering expenses Proceeds From Issuance Of Long Term Debt Proceeds from long term debt Payments Of Debt Issuance Costs Debt issuance costs Debt issuance costs paid Payments Of Debt Extinguishment Costs Extinguishment of debt Payments of extinguishment of debt exit fees. Payments Of Extinguishment Of Debt Exit Fees Extinguishment of debt exit fees Repayments of Long-term Debt Principal repayment of long term debt Proceeds From Stock Options Exercised Proceeds from exercised options Net Cash Provided By Used In Financing Activities Net cash provided by financing activities Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CASH, CASH EQUIVALENTS, AND RESTRICTED CASH-End of period CASH, CASH EQUIVALENTS, AND RESTRICTED CASH-Beginning of period Total cash, cash equivalents, and restricted cash shown in the statements of cash flows Supplemental Cash Flow Information [Abstract] Supplemental Disclosure of Cash Flow Information: Interest Paid Net Cash paid during the year for interest Organization Consolidation And Presentation Of Financial Statements [Abstract] Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Organization and Description of Business Liquidity and capital resources. Liquidity And Capital Resources [Abstract] Liquidity and capital resources. Liquidity And Capital Resources [Text Block] Liquidity and Capital Resources Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Investments Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Inventory Disclosure [Abstract] Inventory Disclosure [Text Block] Inventory Intangible Assets Net Excluding Goodwill [Abstract] Intangible Assets Disclosure [Text Block] Intangible Assets License and asset purchase agreements. License and Asset Purchase Agreements [Abstract] Disclosure of license and asset purchase agreements. License and Asset Purchase Agreements [Text Block] License and Asset Purchase Agreements Payables And Accruals [Abstract] Accounts Payable And Accrued Liabilities Disclosure [Text Block] Accrued Expenses Debt Disclosure [Abstract] Debt Disclosure [Text Block] Debt Leases [Abstract] Lessee, Operating Leases [Text Block] Leases Commitments And Contingencies Disclosure [Abstract] Commitments And Contingencies Disclosure [Text Block] Commitments and Contingencies Stockholders Equity Note [Abstract] Stockholders Equity Note Disclosure [Text Block] Stockholders' Equity Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Stock Incentive Plan and Stock-based Compensation Earnings Per Share [Text Block] Earnings per Share Income Tax Disclosure [Abstract] Income Tax Disclosure [Text Block] Income Taxes Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related-party Transactions Basis Of Accounting Policy Policy [Text Block] Basis of Presentation Use Of Estimates Use of Estimates Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy Cash, Cash Equivalents and Restricted Cash Investment, Policy [Policy Text Block] Investments Concentration Risk Credit Risk Concentrations of Risk New Accounting Pronouncements Policy Policy [Text Block] Recently Issued Accounting Pronouncements Schedule Of Restricted Cash And Cash Equivalents [Text Block] Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] Schedule of carrying value and amortized cost of available-for-sale debt securities Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block] Schedule of assets measured at fair value Schedule Of Inventory Current Table [Text Block] Schedule of Inventory Net Scheduleof Finite Lived Intangible Assets Future Amortization Expense Table [Text Block] Schedule of Expected Future Annual Amortization Expense for Unamortized Intangible Assets Schedule Of Finite Lived Intangible Assets Table [Text Block] Schedule of Gross Carrying Amount and Net Book Value of Intangible Assets Schedule Of Accrued Liabilities Table [Text Block] Schedule of Accrued Expenses Schedule Of Debt Table [Text Block] Balances of Long-term debt, net Contractual Obligation Fiscal Year Maturity Schedule Table Text Block Future Minimum Payments Relating to Long Term Debt Interest Income And Interest Expense Disclosure Table [Text Block] Interest Expense Related to Long Term Debt Lease, Cost [Table Text Block] Schedule of supplemental balance sheet and cash flow information related to operating leases Lessee Operating Lease Liability Maturity Table [Text Block] Schedule of future payments under noncancelable operating leases Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Changes in Stock Options Granted Schedule Of Share Based Compensation Stock Appreciation Rights Award Activity Table [Text Block] Summary of Changes in SARs Granted Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block] Summary of Changes in RSUs Granted Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Summary of Assumptions Used to Value Awards Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Summary of Stock-based Compensation Expense Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Summary of Computation of Basic and Diluted Net Income per Share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share Organization and description of business. Organization And Description Of Business [Table] Organization And Description Of Business [Table] Subsidiary Sale Of Stock [Axis] Sale of Stock IPO Over-Allotment Option Organization and description of business. Organization And Description Of Business [Line Items] Organization And Description Of Business [Line Items] Shares Issued Price Per Share Shares issued, price per share Proceeds From Issuance Initial Public Offering Proceeds from issuance of common stock upon initial public offering Stock Issued During Period Shares Conversion Of Convertible Securities Common stock issued Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Purchase of common stock upon exercise of warrants Investments and Cash Cash, cash equivalents and investments Summary of significant accounting policies. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Major Customers [Axis] Customer Three customers. Three Customers Caremark LLC. Caremark LLC PANTHERx Specialty Pharmacy LLC. PANTHERx Specialty Pharmacy LLC Accredo Health Group, Inc. Accredo Health Group, Inc Concentration Risk By Benchmark [Axis] Concentration Risk Benchmark Accounts Receivable Product Revenues Concentration Risk By Type [Axis] Concentration Risk Type Customer Concentration Risk Summary of significant accounting policies. Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Number Of financial institutions in which Substantially all of the Company's cash and money market funds are held. Concentrations of Risk, Number Of Financial Institutions Number Of financial institutions Number of major customers. Number Of Major Customers Number of customers Concentration Risk Percentage1 Concentration risk percentage Debt Securities, Available-for-Sale [Table] Financial Instrument [Axis] Financial Instrument Financial Instruments Financial Instruments Short-term Represents the information pertaining to short term commercial paper. Short-term commercial paper Represents the information pertaining to short term corporate debt securities. Short-term corporate debt securities Represents the information pertaining to short term us government securities. Short-term U.S. government securities Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of more than one year from the date of the balance sheet. Long-term Represents the information pertaining to long term corporate debt securities. Long-term corporate debt securities Represents the information pertaining to long term us government securities. Long-term U.S. government securities Range [Axis] Statistical Measurement Minimum Minimum Maximum Maximum Debt Securities, Available-for-Sale [Line Items] Investment securities Debt Securities, Available-for-Sale, Amortized Cost Amortized cost Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Debt Securities, Available-for-Sale Fair Value Maturity term of non current investments. Non Current Investment Maturity Term Non current investment maturity term Fair Value, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 Fair Value, Inputs, Level 2 [Member] Level 2 Cash and Cash Equivalents [Member] Cash equivalents Commercial Paper [Member] Commercial paper Corporate Debt Securities [Member] Corporate debt securities US Government Agencies Debt Securities [Member] U.S. government securities Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assets, Fair Value Disclosure [Abstract] Assets Assets, Fair Value Disclosure Assets Inventory Raw Materials Raw materials Inventory Work In Process Work in process Inventory Finished Goods Finished goods Inventory Gross Inventory, gross Inventory Valuation Reserves Reserve for excess inventory Schedule Of Finite Lived Intangible Assets [Table] Schedule Of Finite Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] WAKIX. Upon FDA Approval of WAKIX WAKIX NDA for WAKIX. NDA for WAKIX [Member] NDA for WAKIX. Product Or Service [Axis] Product and Service Daytime Sleepiness. Daytime Sleepiness Cataplexy. Cataplexy Statement Geographical [Axis] Geographical United States Finite Lived Intangible Assets [Line Items] Finite Lived Intangible Assets [Line Items] License agreement milestone payments paid. License Agreement Milestone Payments Paid License agreement milestone payments paid License agreement final payment paid. License Agreement Final Payment Paid Final payment paid Finite Lived Intangible Asset Useful Life Useful life of intangible asset Finite Lived Intangible Assets Remaining Amortization Period1 Remaining useful life Finite Lived Intangible Assets Net Amortization Expense Fiscal Maturity [Abstract] Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year 2022 (Excluding the nine months ended September 30, 2022) Finite-Lived Intangible Asset, Expected Amortization, Year One 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Two 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Three 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Four 2026 Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date Finite-Lived Intangible Asset, Expected Amortization, after Year Four Thereafter Finite Lived Intangible Assets Net Total Intangible Assets Gross Excluding Goodwill Gross Carrying Amount Finite Lived Intangible Assets Accumulated Amortization Accumulated Amortization Disclosure of information about license and asset purchase agreements. License and Asset Purchase Agreements [Table] Counterparty Name [Axis] Counterparty Name Bioprojet. Bioprojet Statement Scenario [Axis] Scenario Upon achievement of aggregate net sales. Attaining $500,000 Aggregate Net Sales Represents the information pertaining to all countries except Greater China. All Countries Excluding Greater China Pitolisant's. Upon Acceptance by FDA of Pitolisant's Sales-based, Trademark and Tiered Royalties Represents information pertaining to HBS 102. HBS-102 Asset Acquisition [Axis] Asset Acquisition [Domain] Represents the information pertaining to asset purchase agreement with ConSynance Therapeutics. Asset Purchase Agreement with ConSynance Therapeutics [Member] Income Statement Location [Axis] Income Statement Location Research and Development Expense Research and Development Expense Line items represent License and asset purchase agreements. License and Asset Purchase Agreements [Line Items] License agreement milestone payments Due. License Agreement Milestone Payments Due License agreement, milestone payment due Licensing agreement milestone fees Licensing Agreement Milestone Fees Licensing agreement milestone fees License agreement additional milestone payments due. License Agreement Additional Milestone Payments Due License agreement, additional milestone payment due Amount of aggregate net sales attaining. Amount Of Aggregate Net Sales Attaining Amount of Aggregate Net Sales Attaining Accrued Royalties Current Royalties due to third parties Accrued Sales Based Trademark and Royalties Asset Acquisition, Consideration Transferred Consideration transferred The amount of intellectual property payment due upon achievement of preclinical milestones. Intellectual Property Payment Due Upon Achievement of Preclinical Milestones Payment for intellectual property upon preclinical milestones The amount of intellectual property payment due upon achievement of developmental milestones. Intellectual Property Payment Due Upon Achievement of Developmental Milestones Payment for intellectual property upon developmental milestones The amount of intellectual property payment due upon achievement of sales milestones. Intellectual Property Payment Due Upon Achievement of Sales Milestones Payment for intellectual property upon sales milestones The amount of intellectual property payment due upon achievement of regulatory milestones. Intellectual Property Payment Due Upon Achievement of Regulatory Milestones Payment for intellectual property upon regulatory milestones Represents information pertaining to license agreement upfront non-refundable fees paid. License Agreement Upfront Non-Refundable Fee Paid License agreement, upfront non-refundable licensing fees paid License agreement maximum additional milestone payments due. License Agreement Maximum Additional Milestone Payments Due License agreement, maximum additional milestone payment due Accrued rebates and other sales deductions. Accrued Rebates And Other Sales Deductions Current Rebates and other sales deductions Interest Payable, Current Interest Accrued Marketing Costs Current Selling and marketing Accrued research and development current Accrued Research And Development Current Research and development Accrued professional fees, consulting, and other services. Accrued Professional Fees Consulting And Other Services Professional fees, consulting, and other services Represents information related to accrued licensing fee. Accrued Licensing Fee Current Licensing fee Other Accrued Liabilities Current Other expenses Debt Instrument [Table] Debt Instrument [Table] Debt Instrument [Axis] Debt Instrument, Name Senior secured term loan. Senior Secured Term Loan Senior secured delayed draw term loan. Senior Secured Delayed Draw Term Loan Line Of Credit Facility [Axis] Line of Credit Facility, Lender Blackstone Alternative Credit Advisors ("Blackstone"). Blackstone Alternative Credit Advisors ("Blackstone") Variable Rate [Axis] Variable Rate [Domain] London Interbank Offered Rate (LIBOR) [Member] Represents the information pertaining to repayment of debt commencing on December 31, 2021. Repayment of Debt Commencing on December 31, 2021 Represents the information pertaining to repayment of debt beginning on March 31, 2024. Repayment of Debt Beginning on March 31, 2024 Represents the information pertaining to repayment of debt Due on Maturity Date of August 9, 2026. Repayment of Debt Due on Maturity Date Debt Instrument [Line Items] Debt Instrument [Line Items] Line Of Credit Facility Maximum Borrowing Capacity Aggregate principal amount Debt Instrument, Periodic Payment, Principal Periodic payment principal Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Percentage of ticking fee Debt Instrument Basis Spread On Variable Rate1 Basis spread on variable rate Deferred Finance Costs Gross Debt issuance costs Proceeds From Issuance Of Debt Cash proceeds received Debt Instrument Term Term of loan Debt Instrument Fair Value Fair value of loan Debt Instrument Carrying Amount Total Liability component - principal Unamortized debt discount associated with exit fee, debt financing costs and discount with warrant financing. Unamortized Debt Discount Associated With Exit Fee Debt Financing Costs And Discount With Warrant Financing Unamortized debt discount associated with debt financing costs Long-term Debt Liability component - net carrying value Long-term Debt, Fiscal Year Maturity [Abstract] Long-Term Debt, Maturity, Remainder of Fiscal Year 2022 (Excluding the nine months ended September 30, 2022) Long-Term Debt, Maturity, Year One 2023 Long-Term Debt, Maturity, Year Two 2024 Long-Term Debt, Maturity, Year Three 2025 Long-Term Debt, Maturity, Year Four 2026 Interest Expense Debt Excluding Amortization Interest on principal balance Interest Expense Debt Total term loan interest expense Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Operating lease office space. Operating Lease Office Space Operating lease square feet of office space Lessee, Operating Lease, Term of Contract Lease terms Lessee, Operating Lease, Existence of Option to Extend [true false] Lessee, Operating Lease, Existence of Option to Terminate [true false] Operating Lease, Cost Cost operating lease Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term Operating Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate for operating leases No definition available. Operating Lease, Asset [Abstract] Assets Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability [Abstract] Liabilities Operating Lease, Liability, Current Operating lease liability, current portion Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent Operating lease liability, long-term Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability Total operating lease liabilities Operating Lease, Payments Operating cash flows from operating leases Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right of use assets obtained in exchange for operating lease obligations (1) Lessee, Operating Lease, Liability, Payment, Due [Abstract] Years ending December 31, Lessee Operating Lease Liability Payments Remainder Of Fiscal Year 2022 (Excluding the nine months ended September 30, 2022) Lessee Operating Lease Liability Payments Due Next Twelve Months 2023 Lessee Operating Lease Liability Payments Due Year Two 2024 Lessee Operating Lease Liability Payments Due Year Three 2025 Lessee Operating Lease Liability Payments Due Total lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Loss Contingencies [Table] Loss Contingencies [Table] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Loss Contingency, Pending Claims, Number Claims or suits outstanding Schedule Of Stock By Class [Table] Schedule Of Stock By Class [Table] Class Of Stock [Line Items] Class Of Stock [Line Items] Common Stock Voting Rights Common stock, voting rights Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Plan Name [Axis] Plan Name Incentive award plan two thousand twenty. 2020 Plan Two thousand seventeen equity incentive plan and two thousand twenty incentive award plan. 2017 and 2020 Plans Employee Stock Purchase Plan. Employee Stock Purchase Plan Award Type [Axis] Award Type Restricted Stock Units (RSUs) [Member] Restricted Stock Units Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period Stock options contractual term Percentage of increment in common stock outstanding . Share Based Compensation, Percentage of Increment in Common Stock Outstanding Annually Percentage of increment of common stock outstanding Stock vested during period shares. Stock Vested During Period Shares Stock vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average per share fair value of awards issued (in USD per share) Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized stock-based compensation expense Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date ESPP permits eligible employees to purchase shares of common stock at discount Common Stock Capital Shares Reserved For Future Issuance Total number of shares available for issuance Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period Shares issued under the ESPP Amount of discount from fair value on purchase date that participants pay for shares. Share-based Compensation Arrangement by Share-based Payment Award, Discount Amount of discount on ESSP Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Number of Awards, Awards outstanding, Ending balance Number of Awards, Awards outstanding, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Number of Awards, Awards issued Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Number of Awards, Awards forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted-Average Exercise Price, Awards outstanding, Ending balance Weighted-Average Exercise Price, Awards outstanding, Beginning balance Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted-Average Exercise Price, Awards issued Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Weighted-Average Exercise Price, Awards exercised Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Weighted-Average Exercise Price, Awards forfeited Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Weighted-Average Remaining Contractual Term Stock Appreciation Rights Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Number of Awards, Awards outstanding, Ending balance Number of Awards, Awards outstanding, Beginning balance Share based compensation arrangement by share based payment award equity instruments other than options exercised in period. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Number of Awards, Awards exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Number of Awards, Awards forfeited Share based compensation arrangement by share based payment award equity instruments other than options non-vested weighted-average exercise price. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price Weighted-Average Exercise Price, Awards outstanding, Ending balance Weighted-Average Exercise Price, Awards outstanding, Beginning balance Share based compensation arrangement by share based payment award equity instruments other than options non-vested weighted-average exercise price exercised in period. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price Exercised In Period Weighted-Average Exercise Price, Awards exercised Share based compensation arrangement by share based payment award equity instruments other than options non-vested weighted-average exercise price forfeited in period. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price Forfeited In Period Weighted-Average Exercise Price, Awards forfeited Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms Weighted-Average Remaining Contractual Term Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum Expected volatility, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum Expected volatility, maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum Risk-free interest rate, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum Risk-free interest rate, maximum Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Expected term (years) Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Sales and Marketing Expense General and Administrative Expense General and Administrative Expense Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Allocated Share Based Compensation Expense Stock-based compensation expense Net Income Loss [Abstract] Numerator Net Income Loss Available To Common Stockholders Basic Net income available to common stockholders Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Share-based Payment Arrangement [Member] Stock options, SARs, and RSUs to purchase common stock Warrants Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Securities outstanding included in computation of utilizing treasury stock method. Securities Outstanding Included In Computation Of Utilizing Treasury Stock Method Total Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Total Deferred Tax Assets Valuation Allowance Valuation allowance Amount of tax benefit related to the release of a valuation allowance on certain deferred tax assets, net. Tax Benefit, Release of Valuation Allowance Tax benefit related to the release of a valuation allowance on certain deferred tax assets, net Amount of tax benefit related to deferred tax assets, net which were utilized in the current period. Tax Benefit, Deferred Tax Assets Utilized Tax benefit related to deferred tax assets, net which were utilized in the current period Schedule Of Related Party Transactions By Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] Related Party Transaction [Axis] Related Party Transaction Management services agreement. Management Services Agreement Related Party Transaction [Line Items] Related Party Transaction [Line Items] Related Party Transaction Expenses From Transactions With Related Party Management fee expense and other expenses to related party Related Party Transaction, Due from (to) Related Party Amounts due to or due from related parties